Moreover, CALR, CASP1, CD4, CXCR3, FOXP3, IFNGR1, IL10, P2RX7, and PRF1 were significantly correlated with the prognosis of AML patients (p < 0.05) (Fig. 1C). Here, PRF1 is linked to acute myeloid leukemia.